ID
45568
Description
Principal Investigator: Elaine Mardis, PhD, The Genome Institute, Washington University School of Medicine, St. Louis, MO, USA MeSH: Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000661 This study aims to elucidate the genetic determinants of susceptibility to aggressive prostate carcinoma. To this end, germ line whole exome sequence has been generated from patients with aggressive prostate cancer. Whole genome sequence for a representative subset of tumors from patients whose cancer was resistant to primary therapy is included as well. This deep genomic interrogation will allow the identification of rare, functionally disruptive variants that may play a role in disease progession and response to treatment.
Lien
Mots-clés
Versions (1)
- 23/01/2023 23/01/2023 - Dr. Christian Niklas
Détendeur de droits
Elaine Mardis, PhD, The Genome Institute, Washington University School of Medicine, St. Louis, MO, USA
Téléchargé le
23 janvier 2023
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000661 Germline Sequencing for Aggressive Prostate Carcinoma
Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- StudyEvent: SEV1
- Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID, sample ID, and sample use variable of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID and race of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Sample ID, body site from which the tissue sample originated, tumor status of sample, and age of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
Similar models
Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- StudyEvent: SEV1
- Subject ID, consent group, and affection status of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID, sample ID, and sample use variable of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Subject ID and race of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
- Sample ID, body site from which the tissue sample originated, tumor status of sample, and age of participants with prostate cancer and involved in the "Germline Sequencing for Aggressive Prostate Carcinoma" project.
C4684638 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,2])